Form 4: Edgewell Director Stahl Acquires Restricted Stock
Insider Transaction Report
Edgewell Personal Care Co. Director Stephanie Stahl acquired 7,817 restricted stock equivalents, converting to common stock, as part of her compensation.
Summary
- Stephanie Stahl, a Director of Edgewell Personal Care Co. (EPC), acquired 7,817 Restricted Stock Equivalents.
- These equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders.
- Stahl has the option to defer the conversion of these restricted stock equivalents until the termination of her service on Edgewell's Board of Directors.
- The transaction date for this acquisition was February 5, 2026.
- The acquisition was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine, slightly positive event as it aligns director interests with shareholders through equity compensation, a common corporate governance practice.
Positives
- Director Stephanie Stahl's acquisition of restricted stock equivalents aligns her interests with those of the company's shareholders.
- The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary transaction, which can reduce concerns about opportunistic insider trading.
Future Outlook
The restricted stock equivalents are scheduled to convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.
Industry Context
StockSavvy.ai notes that director compensation often includes equity awards like restricted stock equivalents, which are a common mechanism to align the interests of board members with long-term shareholder value. This type of grant is standard practice across various industries for retaining and incentivizing key personnel.
Comparison to Industry Standards
- The grant of restricted stock equivalents to a director is a common compensation practice, comparable to similar equity incentive programs at consumer goods companies such as Procter & Gamble (PG) or Kimberly-Clark (KMB), which also utilize stock-based awards to incentivize their board members and executives. The specific amount of 7,817 units would be evaluated against the company's overall compensation philosophy and peer group benchmarks.
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.
- Board of Directors: Standard compensation mechanism for retaining and incentivizing board members.
Next Steps
- Conversion of Restricted Stock Equivalents into common stock on the day preceding the next annual meeting of shareholders.
- Potential deferral of conversion until termination of service on Edgewell's Board of Directors.
Key Dates
| Date | Description |
|---|---|
| 02/05/2026 | Date of earliest transaction for the acquisition of Restricted Stock Equivalents. |
| 02/06/2026 | Signature date of the reporting person on the Form 4 filing. |
Keywords
Edgewell Personal Care, EPC, Stephanie Stahl, Form 4, Restricted Stock Equivalents, Director Compensation, Insider Transaction, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.